KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolent Health (EVH) Operating Leases (2019 - 2025)

Evolent Health (EVH) has 7 years of Operating Leases data on record, last reported at $4.4 million in Q3 2025.

  • For Q3 2025, Operating Leases fell 84.88% year-over-year to $4.4 million; the TTM value through Sep 2025 reached $4.4 million, down 84.88%, while the annual FY2024 figure was $25.0 million, 34.31% down from the prior year.
  • Operating Leases reached $4.4 million in Q3 2025 per EVH's latest filing, down from $32.6 million in the prior quarter.
  • Across five years, Operating Leases topped out at $67.8 million in Q1 2021 and bottomed at $4.4 million in Q3 2025.
  • Average Operating Leases over 5 years is $47.8 million, with a median of $56.0 million recorded in 2022.
  • The widest YoY moves for Operating Leases: up 12.41% in 2025, down 84.88% in 2025.
  • A 5-year view of Operating Leases shows it stood at $57.7 million in 2021, then fell by 2.97% to $56.0 million in 2022, then tumbled by 32.14% to $38.0 million in 2023, then plummeted by 34.31% to $25.0 million in 2024, then plummeted by 82.25% to $4.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for Operating Leases were $4.4 million in Q3 2025, $32.6 million in Q2 2025, and $50.8 million in Q1 2025.